2019 American Transplant Congress
A Pilot Study of the mDOT Platform for Immunosuppression Adherence in Adult Kidney Transplant Recipients
Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: The leading predictor of rejection, de novo DSA, graft loss, and death among adult kidney transplant (KT) recipients is immunosuppressive medication nonadherence. An estimated…2019 American Transplant Congress
Predicting Transplant Rejection by a Composite Urinary Injury Score
Department of Surgery, UCSF, San Francisco, CA
*Purpose: While sequencing or SNP-based methods of quantifying donor-derived cell-free DNA (dd-cfDNA) from plasma have been used to detect allograft rejection, they remain expensive and…2019 American Transplant Congress
Use of TruGraf Serial Testing for Confirming Stability in Kidney Transplant Patients with Stable Renal Function
1California Pacific Med Ctr, San Francisco, CA, 2Transplant Genomics Inc, Mansfield, MA
*Purpose: The objectives of this study were to model serial TruGraf testing in stable kidney transplant recipients and to demonstrate the potential clinical utility of…2019 American Transplant Congress
Retrospective Nested Case Control Study of the Impact of Immunosuppression on Post Transplant Malignancy among Adult Heart Transplant Patients
*Purpose: Post-transplant malignancy is diagnosed in approximately 18% of heart transplant (HTx) recipients and is a leading long-term cause of death among these patients. The…2019 American Transplant Congress
Increasing Time-in-Therapeutic Range of Tacrolimus is Associated with Superior Outcomes in Living Kidney Transplants
*Purpose: Tacrolimus-based regimens remain the backbone of maintenance immunosuppressive therapy in kidney transplant, and therapeutic drug monitoring of tacrolimus is necessary due to a narrow…2019 American Transplant Congress
Mathematical Model of Post-Transplant Serum Creatinine
*Purpose: Commonly used equations calculating eGFR are not applicable when serum creatinine (Scr) is rapidly changing such as the post-transplant period. The purpose of this…2019 American Transplant Congress
EBV+ PTLD in the Modern Immunosuppression Era: Role of EBV Serology and DNAemia-Preliminary Data from CTOT-C06
*Purpose: Post-transplant lymphoproliferative disorder (PTLD) remains a serious problem in the pediatric transplant population. The Clinical Trials of Organ Transplantation in Children (CTOT-C)-06 is an…2019 American Transplant Congress
Tacrolimus Concentrations Can Be Reliably Measured in Capillary Microsamples
Oslo University Hospital, Rikshospitalet, Oslo, Norway
*Purpose: Routine therapeutic drug monitoring (TDM) of tacrolimus (Tac) is currently performed in venous bloods samples drawn at the hospital. The novel volumetric absorptive microsampling…2019 American Transplant Congress
Natural Evolution Of Tacrolimus Intra-patient Variability Among Renal Transplant Recipients
University of Cincinnati, Cincinnati, OH
*Purpose: High tacrolimus (TAC) intra-patient variability (IPV) has been correlated with negative outcomes post renal transplant (RT). The natural evolution of TAC IPV remains uncharacterized…2019 American Transplant Congress
Challenges to Inpatient Management Post Abdominal Wall Transplant (AWT) – From App’s Perspective
Duke University hospital, Durham, NC
*Purpose: To highlight the unique features of caring for an AWT recipient and identify areas of improvement for future cases*Methods: AWT is an innovative adjunct…
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 22
- Next Page »